[1] |
王炯波,徐文莉,孙丽萍. 参松养心胶囊治疗冠心病心律失常疗效分析[J]. 白求恩军医学院学报,2007,5(1):34-35.
|
[2] |
吴仕君,王胜梅. 冠心病患者血清Hcy和Cys C水平的变化[J]. 检验医学,2014,29(4): 327.
|
[3] |
官燕飞,彭建明,叶贵诚,等. 单胎及双胎妊娠对血清半胱氨酸蛋白酶抑制剂C水平的影响[J]. 检验医学,2014,29(1):93-94.
|
[4] |
AYUB S,ZAFAR M N,AZIZ T,et a1.Evaluation of renal function by cystatin C in renal transplant recipients[J].Exp Clin Transplant,2014,12(1):37-40.
|
[5] |
姜宇海,王亚平. 冠心病患者同型半胱氨酸的变化及其临床价值[J]. 检验医学,2014,29(5): 576-577.
|
[6] |
AKGUL O,UYAREL H,ERGELEN M,et al.Predictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction[J]. J Crit Care,2013,28(5):e13-e20.
|
[7] |
VIEIRA C,NABAIS S,RAMOS V,et al.Multimarker approach with cystatin C,N-terminal pro-brain natriuretic peptide ,C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes[J]. Rev Port Cardiol,2014,33(3):127-136.
|
[8] |
刘君. 胱抑素C检测在冠心病患者中的临床意义研究[J]. 实用心脑肺血管病杂志,2011,19(1):16-17.
|
[9] |
BENGTSSON E,TO F,GRUBB A,et al.Absence of the protease inhibitor cystatin C in inflammatory cells results in larger area in plaque regression of apoE-deficient mice[J]. Atherosclerosis,2005,280(1):45-53.
|
[10] |
ERIKSSON P,DEGUCHI H,SAMNEGARD A,et al.Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease[J]. Arterioscler Thromb Vasc Biol,2004,24(3):551-557.
|
[11] |
徐志强,周赟,王骏. 胱抑素C rs1064039位点单核苷酸基因多态性与冠心病的相关性研究[J]. 临床心血管病杂志,2015,31(2):152-155.
|
[12] |
DE SERVI S,MARIANI G,PIATTI T,et al.Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes[J]. J Cardiovasc Med(Hagerstown),2014,15(1):42-47.
|
[13] |
郭进京,居军,徐向红,等. 胱抑素C基因多态性、载脂蛋白E基因多态性与冠心病的相关性探讨[J]. 现代检验医学杂志,2009,24(1):40-43.
|